基于细胞的Lumit p-ERK免疫分析分析致癌KRAS突变药物。

{"title":"基于细胞的Lumit p-ERK免疫分析分析致癌KRAS突变药物。","authors":"Matthew R Swiatnicki, Laurie Engel, Riva Shrestha, Juliano Alves, S. Goueli, H. Zegzouti","doi":"10.1016/j.slasd.2022.03.001","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":74806,"journal":{"name":"SLAS discovery : advancing life sciences R & D","volume":"30 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Profiling oncogenic KRAS mutant drugs with a cell-based Lumit p-ERK immunoassay.\",\"authors\":\"Matthew R Swiatnicki, Laurie Engel, Riva Shrestha, Juliano Alves, S. Goueli, H. Zegzouti\",\"doi\":\"10.1016/j.slasd.2022.03.001\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":74806,\"journal\":{\"name\":\"SLAS discovery : advancing life sciences R & D\",\"volume\":\"30 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"SLAS discovery : advancing life sciences R & D\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1016/j.slasd.2022.03.001\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"SLAS discovery : advancing life sciences R & D","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.slasd.2022.03.001","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}